These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22542050)

  • 21. Treating rheumatoid arthritis with tumour necrosis factor alpha blockade.
    Emery P; Buch M
    BMJ; 2002 Feb; 324(7333):312-3. PubMed ID: 11834544
    [No Abstract]   [Full Text] [Related]  

  • 22. Infliximab for rheumatoid arthritis in a patient with tuberculosis.
    Matsumoto T; Tanaka T; Kawase I
    N Engl J Med; 2006 Aug; 355(7):740-1. PubMed ID: 16914717
    [No Abstract]   [Full Text] [Related]  

  • 23. Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection.
    Schafranski MD
    Rheumatol Int; 2010 Mar; 30(5):679-80. PubMed ID: 19466419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-TNF agents for rheumatoid arthritis.
    Seymour HE; Worsley A; Smith JM; Thomas SH
    Br J Clin Pharmacol; 2001 Mar; 51(3):201-8. PubMed ID: 11298065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tumour necrosis factor treatment in a patient with anorexia nervosa and juvenile idiopathic arthritis.
    Barber J; Sheeran T; Mulherin D
    Ann Rheum Dis; 2003 May; 62(5):490-1. PubMed ID: 12695170
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolonged efficacy of infliximab for refractory adult-onset Still's disease.
    Dilhuydy MS; Vatan R; Etienne G; Longy-Boursier M; Mercié P
    Clin Exp Rheumatol; 2005; 23(1):121-2. PubMed ID: 15789901
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Verhoeven AC; Boers M
    Ned Tijdschr Geneeskd; 2001 Nov; 145(47):2294-5. PubMed ID: 11760611
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor necrosis factor-alpha blocker induced tuberculosis.
    Kharbanda P; Dagaonkar R; Balakrishnan C; Udwadia ZF
    J Rheumatol; 2010 Jul; 37(7):1542; author reply 1543. PubMed ID: 20595292
    [No Abstract]   [Full Text] [Related]  

  • 29. When should we use TNF antagonists in children with rheumatic disease?
    Quartier P
    Joint Bone Spine; 2007 Jan; 74(1):1-3. PubMed ID: 17174585
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis.
    Seriolo B; Paolino S; Ferrone C; Cutolo M
    Clin Rheumatol; 2007 Oct; 26(10):1799-800. PubMed ID: 17646897
    [No Abstract]   [Full Text] [Related]  

  • 31. Detecting latent tuberculosis infection during anti-tumor necrosis factor therapy.
    Ringrose JS; Sanche SE; Taylor-Gjevre RM
    Clin Exp Rheumatol; 2011; 29(5):790-4. PubMed ID: 21961892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour necrosis factor blockade in rheumatoid arthritis.
    Breedveld FC
    Clin Med (Lond); 2001; 1(2):107-9. PubMed ID: 11333452
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of anorexia nervosa with TNF-α down-regulating agents.
    Bou Khalil R; de Muylder O; Hebborn FL
    Eat Weight Disord; 2011 Dec; 16(4):e300. PubMed ID: 22526138
    [No Abstract]   [Full Text] [Related]  

  • 34. Cigarette smoking, TB, and TNF inhibitors.
    Bieber J; Kavanaugh A
    Ann Rheum Dis; 2003 Nov; 62(11):1118-9. PubMed ID: 14583580
    [No Abstract]   [Full Text] [Related]  

  • 35. TNFalpha inhibition in psoriatic arthritis: cause for hope.
    Zabraniecki L; Fournié B
    Joint Bone Spine; 2001 Mar; 68(2):106-8. PubMed ID: 11324924
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].
    González-Gay MA; Agudo M
    Med Clin (Barc); 2010 May; 134(15):684-5. PubMed ID: 20176386
    [No Abstract]   [Full Text] [Related]  

  • 37. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
    Leccese P; D'Angelo S; Angela P; Coniglio G; Olivieri I
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S102. PubMed ID: 20868587
    [No Abstract]   [Full Text] [Related]  

  • 38. Infliximab treatment for rheumatic disease: clinical and radiological efficacy.
    St Clair EW
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii67-9. PubMed ID: 12379627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.
    Finckh A; Simard JF; Gabay C; Guerne PA;
    Ann Rheum Dis; 2006 Jun; 65(6):746-52. PubMed ID: 16339288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which TNF inhibitor for rheumatoid arthritis?
    Med Lett Drugs Ther; 2010 May; 52(1338):38-9. PubMed ID: 20467356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.